NCT06708520View on ClinicalTrials.gov

Pharmacokinetics and Safety of Rupatadine in Participants With Renal Impairment Compared to Control Participants

PHASE1RecruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

November 21, 2022

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions
Renal Impairment
Interventions
DRUG

Rupatadine

10 mg tablets

Trial Locations (7)

8916

RECRUITING

Hospital Universitari Germans Trias I Pujol, Badalona

28006

RECRUITING

Hospital Universitario De La Princesa, Madrid

4434-502

RECRUITING

Centro Hospitalar De Vila Nova De Gaia Espinho, Gaia

4450-113

RECRUITING

Hospital Pedro Hispano, Matosinhos Municipality

4250-449

RECRUITING

Blueclinical Investigacao E Desenvolvimento Em Saude Lda., Porto

08003

RECRUITING

Municipal Institute Of Medical Investigation, Barcelona

08025

RECRUITING

Hospital De La Santa Creu I Sant Pau, Barcelona

Sponsors

Lead Sponsor

Noucor Health S.A.
All Listed Sponsors
lead

Noucor Health S.A.

INDUSTRY

NCT06708520 - Pharmacokinetics and Safety of Rupatadine in Participants With Renal Impairment Compared to Control Participants | Biotech Hunter | Biotech Hunter